Skip to content
Article Rich – Lifestyle
Author:
DIAGNOS Inc.
DIAGNOS Announces Amendment to Convertible Debentures
May 21, 2026
DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA
April 8, 2026
DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration
April 1, 2026
DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants
March 6, 2026
DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference
March 4, 2026